Signaling Pathways - Bladder Carcinoma - Neurocognitive Disorders - Thyroid Cancer
清除全部
- B2186 GSK2636771Target: PI3KSummary: PIK3抑制剂
- A2174 Lenvatinib (E7080)中文名: 乐伐替尼,仑伐替尼Target: VEGFR|PDGFR|RETSummary: VEGFR抑制剂
- A3632 Motesanib中文名: 莫特塞尼Target: VEGFRSummary: Flk-1/Flt-4/PDGFR-/c-Kit抑制剂
- A3573 LY2801653Target: METSummary: MET抑制剂
- A3194 AST 4871 CitationTarget: RETSummary: RET激酶抑制剂
- A4383 Tolcapone中文名: 托卡朋Target: Catechol O-Methyltransferase (COMT)Summary: COMT抑制剂
- A4365 Lovastatin中文名: 洛伐他汀Target: HMG-CoA ReductasesSummary: HMG-CoA还原酶抑制剂
- A1915 Zebularine1 Citation中文名: 泽布拉林Target: DNA Methyltransferases|Cytidine deaminasesSummary: DNA甲基化抑制剂
- A4111 VX-680 (MK-0457,Tozasertib)中文名: 陶扎色替Target: Aurora KinasesSummary: Aurora 激酶抑制剂
- A3016 PLX-47201 CitationTarget: RafSummary: BRAF激酶抑制剂